• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者非酒精性脂肪性肝病与QTc间期的关联

Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.

作者信息

Targher Giovanni, Valbusa Filippo, Bonapace Stafano, Bertolini Lorenzo, Zenari Luciano, Pichiri Isabella, Mantovani Alessandro, Zoppini Giacomo, Bonora Enzo, Barbieri Enrico, Byrne Christopher D

机构信息

Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy.

Division of General Medicine, "Sacro Cuore" Hospital of Negrar, Verona, Italy.

出版信息

Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):663-9. doi: 10.1016/j.numecd.2014.01.005. Epub 2014 Jan 21.

DOI:10.1016/j.numecd.2014.01.005
PMID:24594085
Abstract

BACKGROUND AND AIMS

The relationship between nonalcoholic fatty liver disease (NAFLD) and prolonged heart rate-corrected QT (QTc) interval, a risk factor for ventricular arrhythmias and sudden cardiac death, is currently unknown. We therefore examined the relationship between NAFLD and QTc interval in patients with type 2 diabetes.

METHODS AND RESULTS

We studied a random sample of 400 outpatients with type 2 diabetes. Computerized electrocardiograms were performed for analysis and quantification of QTc interval. NAFLD was diagnosed by ultrasonographic detection of hepatic steatosis in the absence of other liver diseases. Mean QTc interval and the proportion of those with increased QTc interval (defined as either QTc interval above the median, i.e. ≥416 ms, or QTc interval >440 ms) increased steadily with the presence and ultrasonographic severity of NAFLD. NAFLD was associated with increased QTc interval (odds ratio [OR] 2.16, 95% CI 1.4-3.4, p < 0.001). Adjustments for age, sex, smoking, alcohol consumption, BMI, hypertension, electrocardiographic left ventricular hypertrophy, diabetes-related variables and comorbid conditions did not attenuate the association between NAFLD and increased QTc interval (adjusted-OR 2.26, 95% CI 1.4-3.7, p < 0.001). Of note, the exclusion of those with established coronary heart disease or peripheral artery disease from analysis did not appreciably weaken this association.

CONCLUSION

This is the first study to demonstrate that the presence and severity of NAFLD on ultrasound is strongly associated with increased QTc interval in patients with type 2 diabetes even after adjusting for multiple established risk factors and potential confounders.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)与心率校正QT间期延长(QTc间期延长)之间的关系尚不明确,而QTc间期延长是室性心律失常和心源性猝死的一个危险因素。因此,我们研究了2型糖尿病患者中NAFLD与QTc间期之间的关系。

方法与结果

我们对400例2型糖尿病门诊患者进行了随机抽样研究。通过计算机化心电图分析和量化QTc间期。在排除其他肝脏疾病的情况下,通过超声检测肝脂肪变性来诊断NAFLD。随着NAFLD的出现及其超声严重程度的增加,平均QTc间期以及QTc间期延长者(定义为QTc间期高于中位数,即≥416毫秒,或QTc间期>440毫秒)的比例稳步上升。NAFLD与QTc间期延长相关(比值比[OR]为2.16,95%可信区间为1.4 - 3.4,p < 0.001)。对年龄、性别、吸烟、饮酒、体重指数、高血压、心电图左心室肥厚、糖尿病相关变量和合并症进行校正后,并未减弱NAFLD与QTc间期延长之间的关联(校正后OR为2.26,95%可信区间为1.4 - 3.7,p < 0.001)。值得注意的是,在分析中排除已确诊冠心病或外周动脉疾病的患者后,这种关联并未明显减弱。

结论

这是第一项研究表明,即使在调整了多个既定危险因素和潜在混杂因素后,超声检查显示的NAFLD的存在及其严重程度与2型糖尿病患者QTc间期延长密切相关。

相似文献

1
Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.2型糖尿病患者非酒精性脂肪性肝病与QTc间期的关联
Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):663-9. doi: 10.1016/j.numecd.2014.01.005. Epub 2014 Jan 21.
2
Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population.非酒精性脂肪性肝病与普通人群的QT间期延长有关。
J Am Heart Assoc. 2015 Jul 21;4(7):e001820. doi: 10.1161/JAHA.115.001820.
3
Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.非酒精性脂肪性肝病与住院 2 型糖尿病患者心房颤动的患病率增加有关。
Clin Sci (Lond). 2013 Sep;125(6):301-9. doi: 10.1042/CS20130036.
4
Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus.非酒精性脂肪性肝病与2型糖尿病住院患者发生心脏传导阻滞的风险增加相关。
PLoS One. 2017 Oct 5;12(10):e0185459. doi: 10.1371/journal.pone.0185459. eCollection 2017.
5
Nonalcoholic Fatty Liver Disease Is Related to Abnormal Corrected QT Interval and Left Ventricular Hypertrophy in Chinese Male Steelworkers.非酒精性脂肪性肝病与中国男性钢铁工人校正 QT 间期异常和左心室肥厚有关。
Int J Environ Res Public Health. 2022 Nov 6;19(21):14555. doi: 10.3390/ijerph192114555.
6
Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring.非酒精性脂肪性肝病与 2 型糖尿病患者临床指征 24 小时 Holter 监测时的室性心律失常相关。
Diabetes Care. 2016 Aug;39(8):1416-23. doi: 10.2337/dc16-0091. Epub 2016 May 23.
7
Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease.2型糖尿病合并非酒精性脂肪性肝病患者的心脏瓣膜钙化
Metabolism. 2015 Aug;64(8):879-87. doi: 10.1016/j.metabol.2015.04.003. Epub 2015 May 1.
8
Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.非酒精性脂肪性肝病与1型糖尿病成年患者心血管疾病发病率增加独立相关。
Int J Cardiol. 2016 Dec 15;225:387-391. doi: 10.1016/j.ijcard.2016.10.040. Epub 2016 Oct 17.
9
Nonalcoholic Fatty Liver Disease as a Risk Factor for Prolonged Corrected QT Interval in Apparently Healthy Korean Women.非酒精性脂肪性肝病是韩国健康女性长校正 QT 间期的一个危险因素。
J Gastrointestin Liver Dis. 2020 Mar 13;29(1):59-64. doi: 10.15403/jgld-713.
10
The association between nonalcoholic fatty liver disease and corrected QT interval prolongation among generally healthy Iranian population: Fasa Cohort Study (FACS).非酒精性脂肪性肝病与一般健康伊朗人群校正 QT 间期延长的相关性:法萨队列研究(FACS)。
Clin Cardiol. 2023 Jun;46(6):615-621. doi: 10.1002/clc.24015. Epub 2023 Apr 4.

引用本文的文献

1
Evaluation of the Electrocardiographic Tp-e, Tp-e/QT, and Tp-e/QTc Parameters in Patients with Non-Alcoholic Liver Disease.非酒精性肝病患者心电图Tp-e、Tp-e/QT及Tp-e/QTc参数的评估
Medicina (Kaunas). 2025 Apr 21;61(4):766. doi: 10.3390/medicina61040766.
2
Cardiovascular Manifestations of Patients with Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者的心血管表现
Metabolites. 2025 Feb 23;15(3):149. doi: 10.3390/metabo15030149.
3
Assessment of Liver Involvement in Patients With Type 2 Diabetes Mellitus in Basrah City, Iraq, Using FibroScan and Correlation With Risk Factors.
使用FibroScan评估伊拉克巴士拉市2型糖尿病患者的肝脏受累情况及其与危险因素的相关性。
Cureus. 2024 Jul 22;16(7):e65089. doi: 10.7759/cureus.65089. eCollection 2024 Jul.
4
Patients with atrial fibrillation and diabetes mellitus affected by nonalcoholic fatty liver disease have a greater risk of mortality and worse clinical outcomes.患有心房颤动且患非酒精性脂肪性肝病的糖尿病患者有更高的死亡风险和更差的临床结局。
Cardiovasc Endocrinol Metab. 2024 Jun 4;13(3):e0307. doi: 10.1097/XCE.0000000000000307. eCollection 2024 Sep.
5
New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk.治疗代谢功能障碍相关脂肪性肝病(MASLD)及心血管风险增加患者的新治疗方法
Diagnostics (Basel). 2024 Jan 22;14(2):229. doi: 10.3390/diagnostics14020229.
6
Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study.与代谢功能障碍相关的脂肪性肝病相关的心律失常事件:一项全国性的组织学队列研究。
Cardiovasc Diabetol. 2023 Dec 13;22(1):343. doi: 10.1186/s12933-023-02070-5.
7
How non-alcoholic fatty liver disease and cirrhosis affect the heart.非酒精性脂肪性肝病和肝硬化如何影响心脏。
Hepatol Int. 2023 Dec;17(6):1333-1349. doi: 10.1007/s12072-023-10590-1. Epub 2023 Sep 28.
8
Risk Scores for Prediction of Major Cardiovascular Events in Non-Alcoholic Fatty Liver Disease: A No Man's Land?非酒精性脂肪性肝病主要心血管事件预测的风险评分:一片空白领域?
Life (Basel). 2023 Mar 23;13(4):857. doi: 10.3390/life13040857.
9
The association between nonalcoholic fatty liver disease and corrected QT interval prolongation among generally healthy Iranian population: Fasa Cohort Study (FACS).非酒精性脂肪性肝病与一般健康伊朗人群校正 QT 间期延长的相关性:法萨队列研究(FACS)。
Clin Cardiol. 2023 Jun;46(6):615-621. doi: 10.1002/clc.24015. Epub 2023 Apr 4.
10
[Nonalcoholic fatty liver disease : Hepatic manifestations of metabolic syndrome].[非酒精性脂肪性肝病:代谢综合征的肝脏表现]
Inn Med (Heidelb). 2023 Apr;64(4):323-328. doi: 10.1007/s00108-022-01448-z. Epub 2022 Dec 29.